Patrick A. Kenney, MD

• Adam Benjamin Hittelman
• Benjamin Press
• Daniel Boffa
• Jaime A. Cavallo
• Joseph Brito
• Justin Nguyen
• Marianne Lennon
• Michael S. Leapman
• Michelle Salazar
• Piruz Motamedinia
• Preston C. Sprenkle
• Richard A Martinello

Carcinoma, Renal Cell; Health Services; Nephrectomy; Quality of Health Care; Health Care Quality, Access, and Evaluation; Neoadjuvant Therapy; Cytoreduction Surgical Procedures

• Association Between Private Equity Acquisition of Urology Practices and Physician Medicare PaymentsNie J, Hsiang W, Lokeshwar SD, McMahon G, Demkowicz PC, Kenney PA, Breyer BN, Leapman MS. Association Between Private Equity Acquisition of Urology Practices and Physician Medicare Payments. Urology 2022, 167: 121-127. PMID: 35680053, DOI: 10.1016/j.urology.2022.03.045.
• Vesical clear cell adenocarcinoma of Müllerian origin treated conservatively with partial cystectomyHarold JA, Casilla-Lennon M, Kenney PA, Ratner ES. Vesical clear cell adenocarcinoma of Müllerian origin treated conservatively with partial cystectomy. BMJ Case Reports 2022, 15: e245015. PMID: 35383096, PMCID: PMC8984011, DOI: 10.1136/bcr-2021-245015.
• Cachexia and bladder cancer: clinical impact and managementLokeshwar SD, Press BH, Nie J, Klaassen Z, Kenney PA, Leapman MS. Cachexia and bladder cancer: clinical impact and management. Current Opinion In Supportive And Palliative Care 2021, 15: 260-265. PMID: 34698663, DOI: 10.1097/spc.0000000000000580.
• Urology Practice Acquisitions by Private Equity Firms from 2011–2021Nie J, Demkowicz P, Hsiang W, Umer W, Chen E, McMahon G, Kenney P, Breyer B, Parikh R, Leapman M. Urology Practice Acquisitions by Private Equity Firms from 2011–2021. Urology Practice 2021, 9: 17-24. DOI: 10.1097/upj.0000000000000269.
• Reply by AuthorsNie J, Demkowicz P, Hsiang W, Umer W, Chen E, McMahon G, Kenney P, Breyer B, Parikh R, Leapman M. Reply by Authors. Urology Practice 2021, 9: 24-24. DOI: 10.1097/upj.0000000000000269.02.
• Urology Practice Acquisitions by Private Equity Firms from 2011–2021Nie J, Demkowicz P, Hsiang W, Umer W, Chen E, McMahon G, Kenney P, Breyer B, Parikh R, Leapman M. Urology Practice Acquisitions by Private Equity Firms from 2011–2021. Urology Practice 2021, 9: 17-24. PMID: 37145557, DOI: 10.1097/upj.0000000000000269.
• Reply by AuthorsNie J, Demkowicz P, Hsiang W, Umer W, Chen E, McMahon G, Kenney P, Breyer B, Parikh R, Leapman M. Reply by Authors. Urology Practice 2021, 9: 24-24. PMID: 37145588, DOI: 10.1097/upj.0000000000000269.02.
• PD38-10 AN INITIATIVE TO REDUCE DOOR TO INCISION TIME FOR PATIENTS WITH TESTICULAR TORSIONNguyen J, Buck M, Abello A, Casilla - Lennon M, Leapman M, Hittelman A, Teitelbaum J, Emerson B, Cavallo J, Kenney P, Lambert S. PD38-10 AN INITIATIVE TO REDUCE DOOR TO INCISION TIME FOR PATIENTS WITH TESTICULAR TORSION. Investigative Urology 2021, 206 DOI: 10.1097/ju.0000000000002048.10.
• PD38-07 ANTIBIOTIC PROPHYLAXIS PRIOR TO OUTPATIENT UROLOGIC PROCEDURES: OUTCOMES FROM A DEPARTMENT-WIDE QUALITY IMPROVEMENT PROJECTBuck M, Nguyen J, Abello A, Leapman M, Cavallo J, Kenney P. PD38-07 ANTIBIOTIC PROPHYLAXIS PRIOR TO OUTPATIENT UROLOGIC PROCEDURES: OUTCOMES FROM A DEPARTMENT-WIDE QUALITY IMPROVEMENT PROJECT. Investigative Urology 2021, 206 DOI: 10.1097/ju.0000000000002048.07.
• Access to Urologic Care at Urgent Care CentersHsiang WR, Yousman L, Kim D, Cavallo JA, Kenney PA, Motamedinia P, Breyer B, Leapman MS. Access to Urologic Care at Urgent Care Centers. Urology 2021, 156: 124-128. PMID: 34181971, DOI: 10.1016/j.urology.2021.06.009.
• Change in facility-level share of Medicaid patients with cancer following implementation of the affordable care act.Buck M, Demkowicz P, Nie J, Marks V, Salazar M, Kenney P, Boffa D, Leapman M. Change in facility-level share of Medicaid patients with cancer following implementation of the affordable care act. Journal Of Clinical Oncology 2021, 39: e18543-e18543. DOI: 10.1200/jco.2021.39.15_suppl.e18543.
• Accessibility of Telehealth services for cancer care at cancer hospital in the United States.Marks V, Hsiang W, Nie J, Umer W, Haleem A, Galal B, Pak I, Kim D, Kenney P, Leapman M. Accessibility of Telehealth services for cancer care at cancer hospital in the United States. Journal Of Clinical Oncology 2021, 39: 6535-6535. DOI: 10.1200/jco.2021.39.15_suppl.6535.
• Access to cancer care for Medicaid patients at cancer hospitals in the United States.Marks V, Hsiang W, Nie J, Buck M, Demkowicz P, Umer W, Haleem A, Galal B, Pak I, Kim D, Kenney P, Leapman M. Access to cancer care for Medicaid patients at cancer hospitals in the United States. Journal Of Clinical Oncology 2021, 39: 6548-6548. DOI: 10.1200/jco.2021.39.15_suppl.6548.
• Hydrogen peroxide vapor decontamination of N95 respirators for reuseKenney PA, Chan BK, Kortright KE, Cintron M, Russi M, Epright J, Lee L, Balcezak TJ, Havill NL, Martinello RA. Hydrogen peroxide vapor decontamination of N95 respirators for reuse. Infection Control And Hospital Epidemiology 2021, 43: 45-47. PMID: 33557979, PMCID: PMC8185421, DOI: 10.1017/ice.2021.48.
• Incidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeriesNguyen KA, Le DQ, Bui YT, Advani SD, Renzulli J, Kenney PA, Leapman MS. Incidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeries. World Journal Of Urology 2021, 39: 2995-3003. PMID: 33471163, PMCID: PMC7816064, DOI: 10.1007/s00345-020-03551-y.
• PT414 Similar survival outcomes among chemoradiation and neoadjuvant chemotherapy with radical cystectomy for small cell bladder cancerAbello A, Renzulli J, Park H, Leapman M, Kenney P. PT414 Similar survival outcomes among chemoradiation and neoadjuvant chemotherapy with radical cystectomy for small cell bladder cancer. European Urology Open Science 2020, 19: e2283. DOI: 10.1016/s2666-1683(20)34148-3.
• PT417 National variation in lymph node dissection and pathological yield at the time of radical cystectomyAbello A, Brito J, Sprenkle P, Kenney P, Renzulli J, Leapman M. PT417 National variation in lymph node dissection and pathological yield at the time of radical cystectomy. European Urology Open Science 2020, 19: e2286. DOI: 10.1016/s2666-1683(20)34151-3.
• Analysis of Cost Variation in Endourological Procedures throughout the United States Using a National DatabaseAbello A, Goland-Van Ryn M, Kenney P, Singh D, Motamedinia P. Analysis of Cost Variation in Endourological Procedures throughout the United States Using a National Database. Urology Practice 2020, 7: 174-181. DOI: 10.1097/upj.0000000000000080.
• MP61-12 NATIONAL VARIATION IN LYMPH NODE DISSECTION AND PATHOLOGICAL YIELD AT THE TIME OF RADICAL CYSTECTOMYAbello* A, Nawaf C, Brito J, Sprenkle P, Kenney P, Renzulli J, Leapman M. MP61-12 NATIONAL VARIATION IN LYMPH NODE DISSECTION AND PATHOLOGICAL YIELD AT THE TIME OF RADICAL CYSTECTOMY. Investigative Urology 2020, 203: e939-e940. DOI: 10.1097/ju.0000000000000936.012.
• MP68-05 CLINICAL OUTCOMES OF LOW-STAGE SARCOMATOID RENAL CELL CARCINOMAAbello* A, Nawaf C, Leapman M, Kenney P. MP68-05 CLINICAL OUTCOMES OF LOW-STAGE SARCOMATOID RENAL CELL CARCINOMA. Investigative Urology 2020, 203: e1036. DOI: 10.1097/ju.0000000000000948.05.
• PD55-02 SIMILAR SURVIVAL OUTCOMES AMONG CHEMORADIATION AND NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY FOR SMALL CELL BLADDER CANCERAbello* A, Nawaf C, Renzulli J, Park H, Leapman M, Kenney P. PD55-02 SIMILAR SURVIVAL OUTCOMES AMONG CHEMORADIATION AND NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY FOR SMALL CELL BLADDER CANCER. Investigative Urology 2020, 203 DOI: 10.1097/ju.0000000000000965.02.
• PD05-06 CREATION OF EPIC-BASED DASHBOARD TO TRACK AND REPORT PERIOPERATIVE OUTCOMES AND SURGEON PERFORMANCEJavier-DesLoges* J, Abello A, Kenney P. PD05-06 CREATION OF EPIC-BASED DASHBOARD TO TRACK AND REPORT PERIOPERATIVE OUTCOMES AND SURGEON PERFORMANCE. Investigative Urology 2020, 203 DOI: 10.1097/ju.0000000000000825.06.
• Redefining the Role of Surgical Management of Metastatic Renal Cell CarcinomaHsiang WR, Kenney PA, Leapman MS. Redefining the Role of Surgical Management of Metastatic Renal Cell Carcinoma. Current Oncology Reports 2020, 22: 35. PMID: 32170461, DOI: 10.1007/s11912-020-0895-y.
• Chasing the Pack: Association between Urology Hospital Rankings and Surgical Outcome.Abello A, Leapman M, Kenney PA. Chasing the Pack: Association between Urology Hospital Rankings and Surgical Outcome. Investigative Urology 2019, 203: 890-891. PMID: 32068499, DOI: 10.1097/ju.0000000000000710.
• Open Partial NephrectomyCasilla-Lennon M, Kenney P, Wszolek M, Libertino J. Open Partial Nephrectomy. 2019, 221-242. DOI: 10.1007/978-3-030-24378-4_13.
• Unified Approaches to Surgery and Systemic Therapy for Renal Cell CarcinomaAbello A, Kenney P. Unified Approaches to Surgery and Systemic Therapy for Renal Cell Carcinoma. 2019, 411-435. DOI: 10.1007/978-3-030-24378-4_24.
• Novel Use of the Epic Electronic Medical Record Platform to Identify Lost Ureteral StentsJavier-DesLoges J, Johnson KK, Kenney PA, Motamedinia P. Novel Use of the Epic Electronic Medical Record Platform to Identify Lost Ureteral Stents. Journal Of Endourology 2019, 33: 858-862. PMID: 31418285, DOI: 10.1089/end.2019.0382.
• Outcomes for urologic oncology procedures: are there differences between academic and community hospitals?Syed JS, Abello A, Nguyen J, Lee AJH, Desloges JJ, Leapman MS, Kenney PA. Outcomes for urologic oncology procedures: are there differences between academic and community hospitals? World Journal Of Urology 2019, 38: 1187-1193. PMID: 31420696, DOI: 10.1007/s00345-019-02902-8.
• Analysis of Cost Variation in Endourological Procedures throughout the United States Using a National Database.Abello A, Goland-Van Ryn M, Kenney P, Singh D, Motamedinia P. Analysis of Cost Variation in Endourological Procedures throughout the United States Using a National Database. Urology Practice 2019, 7: 174-181. PMID: 37317390, DOI: 10.1097/upj.0000000000000080.
• Association Between Twitter Reception at a National Urology Conference and Future Publication StatusNolte AC, Nguyen KA, Perecman A, Katz MS, Kenney PA, Cooperberg MR, Gross CP, Leapman MS. Association Between Twitter Reception at a National Urology Conference and Future Publication Status. European Urology Focus 2019, 7: 214-220. PMID: 31103604, DOI: 10.1016/j.euf.2019.05.004.
• PD17-02 CLINICAL RISK BASED ASSOCIATIONS OF LYMPH NODE DISSECTION AND DETECTION YIELD AMONG MEN TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCERAbello* A, Sprenkle P, Kenney P, Leapman M. PD17-02 CLINICAL RISK BASED ASSOCIATIONS OF LYMPH NODE DISSECTION AND DETECTION YIELD AMONG MEN TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER. Investigative Urology 2019, 201 DOI: 10.1097/01.ju.0000555562.32224.0f.
• PD58-05 UROLOGIC MALIGNANCIES: A COMPARISON OF OUTCOMES AFTER INDEX SURGERY BETWEEN ACADEMIC AND COMMUNITY HOSPITALSSyed* J, Abello A, Javier-DesLoges J, Leapman M, Kenney P. PD58-05 UROLOGIC MALIGNANCIES: A COMPARISON OF OUTCOMES AFTER INDEX SURGERY BETWEEN ACADEMIC AND COMMUNITY HOSPITALS. Investigative Urology 2019, 201 DOI: 10.1097/01.ju.0000557173.74355.7e.
• PD66-04 NATIONAL TRENDS AND PATHOLOGIC OUTCOMES OF NEOADJUVANT CHEMOTHERAPY AMONG PATIENTS WITH MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA OF THE BLADDERJavier-DesLoges* J, Abello A, Syed J, Sprenkle P, Hurwitz M, Kenney P, Leapman M. PD66-04 NATIONAL TRENDS AND PATHOLOGIC OUTCOMES OF NEOADJUVANT CHEMOTHERAPY AMONG PATIENTS WITH MICROPAPILLARY VARIANT UROTHELIAL CARCINOMA OF THE BLADDER. Investigative Urology 2019, 201 DOI: 10.1097/01.ju.0000557466.16539.88.
• MP29-19 CHASING THE PACK: ASSOCIATION BETWEEN UROLOGY HOSPITAL RANKINGS AND SURGICAL OUTCOMEAbello* A, Syed J, Leapman M, Kenney P. MP29-19 CHASING THE PACK: ASSOCIATION BETWEEN UROLOGY HOSPITAL RANKINGS AND SURGICAL OUTCOME. Investigative Urology 2019, 201 DOI: 10.1097/01.ju.0000557554.82490.aa.
• Clinical risk-based associations of lymph node dissection and detection of metastasis among men treated with radical prostatectomy.Abello A, Kenney P, Leapman M. Clinical risk-based associations of lymph node dissection and detection of metastasis among men treated with radical prostatectomy. Journal Of Clinical Oncology 2019, 37: 284-284. DOI: 10.1200/jco.2019.37.7_suppl.284.
• Urologic malignancies: A comparison of outcomes after index surgery between academic and community hospitals.Syed J, Abello A, Javier-Desloges J, Leapman M, Kenney P. Urologic malignancies: A comparison of outcomes after index surgery between academic and community hospitals. Journal Of Clinical Oncology 2019, 37: 489-489. DOI: 10.1200/jco.2019.37.7_suppl.489.
• Associations of rurality and disease outcomes in urologic malignancies.Abello A, Casilla-Lennon M, Kenney P, Leapman M. Associations of rurality and disease outcomes in urologic malignancies. Journal Of Clinical Oncology 2019, 37: 661-661. DOI: 10.1200/jco.2019.37.7_suppl.661.
• MP80-02 LEVERAGING STRUCTURED DATA IN AN ENTERPRISE-WIDE ELECTRONIC HEALTH RECORD TO IDENTIFY RISK FACTORS FOR POSTOPERATIVE URINARY RETENTIONJavier-DesLoges J, Amirkhiz K, Su J, Kenney P, Advani S, Hittelman A, Leapman M. MP80-02 LEVERAGING STRUCTURED DATA IN AN ENTERPRISE-WIDE ELECTRONIC HEALTH RECORD TO IDENTIFY RISK FACTORS FOR POSTOPERATIVE URINARY RETENTION. Investigative Urology 2018, 199: e1089. DOI: 10.1016/j.juro.2018.02.2690.
• MP50-13 NOVEL USE OF THE EPIC ELECTRONIC MEDICAL RECORD PLATFORM TO IDENTIFY LOST URETERAL STENTSJavier-Desloges J, Johnson K, Bryson C, Olszyk R, Kenney P, Motamedinia P. MP50-13 NOVEL USE OF THE EPIC ELECTRONIC MEDICAL RECORD PLATFORM TO IDENTIFY LOST URETERAL STENTS. Investigative Urology 2018, 199: e680. DOI: 10.1016/j.juro.2018.02.1624.
• PD04-09 SHOULD PATIENTS WITH METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA UNDERGO CYTOREDUCTIVE NEPHRECTOMY?Keskin S, Petros F, Yu K, Aboshady Y, Borregales L, Kenney P, Matin S, Karam J, Wood C. PD04-09 SHOULD PATIENTS WITH METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA UNDERGO CYTOREDUCTIVE NEPHRECTOMY? Investigative Urology 2017, 197: e65-e66. DOI: 10.1016/j.juro.2017.02.228.
• MP86-17 THE 2017 AMERICAN JOINT COMMITTEE ON CANCER EIGHTH EDITION CANCER STAGING MANUAL: CHANGES IN STAGING GUIDELINES FOR CANCERS OF THE KIDNEY, RENAL PELVIS AND URETER, BLADDER, AND URETHRARobins D, Small A, Amin M, Bochner B, Chang S, Choueiri T, Efstathiou J, Gospodarowicz M, Hansel D, Kenney P, Konety B, Landman J, Lee C, Leibovich B, Plimack E, Reuter V, Rini B, Sridhar S, Stadler W, Tickoo S, Vikram R, Zhou M, McKiernan J. MP86-17 THE 2017 AMERICAN JOINT COMMITTEE ON CANCER EIGHTH EDITION CANCER STAGING MANUAL: CHANGES IN STAGING GUIDELINES FOR CANCERS OF THE KIDNEY, RENAL PELVIS AND URETER, BLADDER, AND URETHRA. Investigative Urology 2017, 197: e1163. DOI: 10.1016/j.juro.2017.02.2700.
• KidneyRini B, McKiernan J, Chang S, Choueiri T, Kenney P, Landman J, Leibovich B, Tickoo S, Vikram R, Zhou M, Stadler W. Kidney. 2016, 747-756. DOI: 10.1007/978-3-319-40618-3_60.
• Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy.Kenney PA, Nawaf CB, Mustafa M, Wen S, Wszolek MF, Pettaway CA, Ward JF, Davis JW, Pisters LL. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Canadian Journal Of Urology 2016, 23: 8271-7. PMID: 27347619, PMCID: PMC5512888.
• Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary NodulesAdibi M, Kenney PA, Thomas AZ, Borregales LD, Nogueras-González GM, Wang X, Devine CE, Karam JA, Wood CG. Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules. European Urology 2015, 69: 352-360. PMID: 26382085, DOI: 10.1016/j.eururo.2015.08.053.
• Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomesKenney PA, Vikram R, Prasad SR, Tamboli P, Matin SF, Wood CG, Karam JA. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes. BJU International 2015, 116: 85-92. PMID: 25395040, DOI: 10.1111/bju.12992.
• Predicting pulmonary metastases among patients with indeterminate pulmonary nodules with renal cell carcinoma.Adibi M, Kenney P, Thomas A, Devine C, Karam J, Wood C. Predicting pulmonary metastases among patients with indeterminate pulmonary nodules with renal cell carcinoma. Journal Of Clinical Oncology 2015, 33: 505-505. DOI: 10.1200/jco.2015.33.7_suppl.505.
• Preoperative Predictors of Pathological Lymph Node Metastasis in Patients with Renal Cell Carcinoma Undergoing Retroperitoneal Lymph Node DissectionBabaian KN, Kim DY, Kenney PA, Wood CG, Wong J, Sanchez C, Fang JE, Gerber JA, Didic A, Wahab A, Golla V, Torres C, Tamboli P, Qiao W, Matin SF, Wood CG, Karam JA. Preoperative Predictors of Pathological Lymph Node Metastasis in Patients with Renal Cell Carcinoma Undergoing Retroperitoneal Lymph Node Dissection. Investigative Urology 2014, 193: 1101-1107. PMID: 25390078, DOI: 10.1016/j.juro.2014.10.096.
• 1042 Predictors of occult lymph node metastases in patients with locally advanced renal cell carcinoma: Who should have a lymph node dissection?Babaian K, Kenney P, Karam J, Wood C. 1042 Predictors of occult lymph node metastases in patients with locally advanced renal cell carcinoma: Who should have a lymph node dissection? European Urology Open Science 2014, 13: e1042. DOI: 10.1016/s1569-9056(14)61024-1.
• MP64-03 PREDICTORS OF OCCULT LYMPH NODE METASTASES IN PATIENTS WITH RENAL CELL CARCINOMA: WHO SHOULD UNDERGO A LYMPH NODE DISSECTION?Babaian K, Kenney P, Kim D, Qiao W, Karam J, Wood C. MP64-03 PREDICTORS OF OCCULT LYMPH NODE METASTASES IN PATIENTS WITH RENAL CELL CARCINOMA: WHO SHOULD UNDERGO A LYMPH NODE DISSECTION? Investigative Urology 2014, 191: e701. DOI: 10.1016/j.juro.2014.02.1920.
• Autotaxin–Lysophosphatidic Acid Signaling Axis Mediates Tumorigenesis and Development of Acquired Resistance to Sunitinib in Renal Cell CarcinomaSu SC, Hu X, Kenney PA, Merrill MM, Babaian KN, Zhang XY, Maity T, Yang SF, Lin X, Wood CG. Autotaxin–Lysophosphatidic Acid Signaling Axis Mediates Tumorigenesis and Development of Acquired Resistance to Sunitinib in Renal Cell Carcinoma. Clinical Cancer Research 2013, 19: 6461-6472. PMID: 24122794, PMCID: PMC4191899, DOI: 10.1158/1078-0432.ccr-13-1284.
• Unified Approaches to Surgery and Systemic Therapy for Renal Cell CarcinomaKenney P, Wood C. Unified Approaches to Surgery and Systemic Therapy for Renal Cell Carcinoma. 2013, 155-177. DOI: 10.1007/978-1-4614-7236-0_10.
• Open Partial NephrectomyKenney P, Wszolek M, Libertino J. Open Partial Nephrectomy. 2013, 211-231. DOI: 10.1007/978-1-4614-7236-0_13.
• 1906 PREOPERATIVE PULMONARY EMBOLISM DOES NOT PREDICT POOR POSTSURGICAL OUTCOMES IN RCC PATIENTS WITH VENOUS THROMBUSAbel E, Wood C, Eickstaedt N, Fang J, Kenney P, Bagrodia A, Ramirez D, Gayed B, Downs T, Youssef R, Odom C, Sagalowsky A, Margulis V. 1906 PREOPERATIVE PULMONARY EMBOLISM DOES NOT PREDICT POOR POSTSURGICAL OUTCOMES IN RCC PATIENTS WITH VENOUS THROMBUS. Investigative Urology 2013, 189: e781. DOI: 10.1016/j.juro.2013.02.2325.
• 1073 CLINICAL PREDICTORS FOR THE DEVELOPMENT OF PULMONARY METASTASES AMONG RCC PATIENTS WITH INDETERMINATE PULMONARY NODULESKenney P, Karam J, Levey R, Nogueras-Gonzalez G, Matin S, Tamboli P, Tannir N, Wood C. 1073 CLINICAL PREDICTORS FOR THE DEVELOPMENT OF PULMONARY METASTASES AMONG RCC PATIENTS WITH INDETERMINATE PULMONARY NODULES. Investigative Urology 2013, 189: e440. DOI: 10.1016/j.juro.2013.02.662.
• Outcomes of RCC patients with venous thrombus presenting with pulmonary embolism: A multicenter analysis of 782 consecutive patients.Abel E, Wood C, Kenney P, Eickstaedt N, Bagrodia A, Ramirez D, Gayed B, Youssef R, Odom C, Margulis V. Outcomes of RCC patients with venous thrombus presenting with pulmonary embolism: A multicenter analysis of 782 consecutive patients. Journal Of Clinical Oncology 2013, 31: 433-433. DOI: 10.1200/jco.2013.31.6_suppl.433.
• Preoperative Pulmonary Embolism Does Not Predict Poor Postoperative Outcomes in Patients with Renal Cell Carcinoma and Venous ThrombusAbel EJ, Wood CG, Eickstaedt N, Fang JE, Kenney P, Bagrodia A, Youssef RF, Sagalowsky AI, Margulis V. Preoperative Pulmonary Embolism Does Not Predict Poor Postoperative Outcomes in Patients with Renal Cell Carcinoma and Venous Thrombus. Investigative Urology 2013, 190: 452-457. PMID: 23434945, DOI: 10.1016/j.juro.2013.02.033.
• Percutaneous cryoablation of solitary sporadic renal cell carcinomas.Kenney PA, Karam JA. Percutaneous cryoablation of solitary sporadic renal cell carcinomas. BJU International 2012, 110: E532. PMID: 22583351, DOI: 10.1111/j.1464-410X.2012.11242.x.
• Re: Comparative Effectiveness of Axitinib Versus Sorafenib in Advanced Renal Cell Carcinoma (AXIS): A Randomised Phase 3 TrialKenney PA, Wood CG. Re: Comparative Effectiveness of Axitinib Versus Sorafenib in Advanced Renal Cell Carcinoma (AXIS): A Randomised Phase 3 Trial. European Urology 2012, 62: 182-183. PMID: 22640859, DOI: 10.1016/j.eururo.2012.04.013.
• Integration of Surgery and Systemic Therapy for Renal Cell CarcinomaKenney PA, Wood CG. Integration of Surgery and Systemic Therapy for Renal Cell Carcinoma. Urologic Clinics Of North America 2012, 39: 211-231. PMID: 22487764, DOI: 10.1016/j.ucl.2012.01.005.
• 1802 DOES CYTOREDUCTIVE NEPHRECTOMY IMPROVE SURVIVAL IN NON-CLEAR CELL RENAL CELL CARCINOMA?Kenney P, Chapin B, Culp S, Richey S, González G, Tamboli P, Tannir N, Wood C. 1802 DOES CYTOREDUCTIVE NEPHRECTOMY IMPROVE SURVIVAL IN NON-CLEAR CELL RENAL CELL CARCINOMA? Investigative Urology 2012, 187: e727. DOI: 10.1016/j.juro.2012.02.1833.
• Nodal disease in the setting of metastatic renal cell carcionoma: Can a lymph node dissection alter outcomes?Chapin B, Delacroix S, Kenney P, Nogueras Gonzalez G, Tamboli P, Jonasch E, Tannir N, Wood C. Nodal disease in the setting of metastatic renal cell carcionoma: Can a lymph node dissection alter outcomes? Journal Of Clinical Oncology 2012, 30: 386-386. DOI: 10.1200/jco.2012.30.5_suppl.386.
• HIGHER PERIOPERATIVE MORBIDITY AND IN‐HOSPITAL MORTALITY IN PATIENTS WITH END‐STAGE RENAL DISEASE UNDERGOING NEPHRECTOMY FOR NON‐METASTATIC KIDNEY CANCER: A POPULATION‐BASED ANALYSISKenney PA, Karam JA. HIGHER PERIOPERATIVE MORBIDITY AND IN‐HOSPITAL MORTALITY IN PATIENTS WITH END‐STAGE RENAL DISEASE UNDERGOING NEPHRECTOMY FOR NON‐METASTATIC KIDNEY CANCER: A POPULATION‐BASED ANALYSIS. BJU International 2012, 110: e191-e191. PMID: 22321381, DOI: 10.1111/j.1464-410x.2012.11018.x.
• Unidirectional barbed suture versus standard monofilament for urethrovesical anastomosis during robotic assisted laparoscopic radical prostatectomyManganiello M, Kenney P, Canes D, Sorcini A, Moinzadeh A. Unidirectional barbed suture versus standard monofilament for urethrovesical anastomosis during robotic assisted laparoscopic radical prostatectomy. International Braz J Urol 2012, 38: 89-96. PMID: 22397770, DOI: 10.1590/s1677-55382012000100013.
• chapter 54 Contemporary Open Surgery of the KidneyKenney P, Wotkowicz C, Libertino J. chapter 54 Contemporary Open Surgery of the Kidney. 2012, 1554-1627.e5. DOI: 10.1016/b978-1-4160-6911-9.00054-2.
• Editorial CommentKenney PA, Karam JA. Editorial Comment. Investigative Urology 2011, 187: 492. PMID: 22177914, DOI: 10.1016/j.juro.2011.10.182.
• Nonclamping partial nephrectomy: towards improved nephron sparingWszolek MF, Kenney PA, Libertino JA. Nonclamping partial nephrectomy: towards improved nephron sparing. Nature Reviews Urology 2011, 8: 523-527. PMID: 21811227, DOI: 10.1038/nrurol.2011.103.
• Editorial CommentKenney PA. Editorial Comment. Investigative Urology 2011, 186: 1024-1025. PMID: 21784470, DOI: 10.1016/j.juro.2011.04.120.
• 963 THE RENAL NEPHROMETRY SCORING SYSTEM IS PREDICTIVE OF PARTIAL NEPHRECTOMY COMPLEXITYKenney P, Kozinn S, Lebeis C, Lee Y, Libertino J, Moinzadeh A. 963 THE RENAL NEPHROMETRY SCORING SYSTEM IS PREDICTIVE OF PARTIAL NEPHRECTOMY COMPLEXITY. Investigative Urology 2011, 185: e388-e389. DOI: 10.1016/j.juro.2011.02.931.
• 1254 POSITIVE SURGICAL MARGINS AFTER PARTIAL NEPHRECTOMY FOR PT1 LOCALIZED RENAL CELL CARCINOMA: LOCAL RECURRENCE AND RCC-SPECIFIC SURVIVALFaust W, Kenney P, Moinzadeh A, Libertino J. 1254 POSITIVE SURGICAL MARGINS AFTER PARTIAL NEPHRECTOMY FOR PT1 LOCALIZED RENAL CELL CARCINOMA: LOCAL RECURRENCE AND RCC-SPECIFIC SURVIVAL. Investigative Urology 2011, 185: e502. DOI: 10.1016/j.juro.2011.02.939.
• 966 COMPARISON OF HILAR CLAMPING AND NON-HILAR CLAMPING PARTIAL NEPHRECTOMY FOR TUMORS INVOLVING A SOLITARY KIDNEYWszolek M, Kenney P, Lee Y, Libertino J. 966 COMPARISON OF HILAR CLAMPING AND NON-HILAR CLAMPING PARTIAL NEPHRECTOMY FOR TUMORS INVOLVING A SOLITARY KIDNEY. Investigative Urology 2011, 185: e389-e390. DOI: 10.1016/j.juro.2011.02.934.
• Comparison of hilar clamping and non‐hilar clamping partial nephrectomy for tumours involving a solitary kidneyWszolek MF, Kenney PA, Lee Y, Libertino JA. Comparison of hilar clamping and non‐hilar clamping partial nephrectomy for tumours involving a solitary kidney. BJU International 2010, 107: 1886-1892. PMID: 21070570, DOI: 10.1111/j.1464-410x.2010.09713.x.
• Non‐clamped partial nephrectomy: techniques and surgical outcomesSmith GL, Kenney PA, Lee Y, Libertino JA. Non‐clamped partial nephrectomy: techniques and surgical outcomes. BJU International 2010, 107: 1054-1058. PMID: 21040369, DOI: 10.1111/j.1464-410x.2010.09798.x.
• Novel ZEB1 expression in bladder tumorigenesisKenney PA, Wszolek MF, Rieger‐Christ K, Neto BS, Gould JJ, Harty NJ, Mosquera JM, Zeheb R, Loda M, Darling DS, Libertino JA, Summerhayes IC. Novel ZEB1 expression in bladder tumorigenesis. BJU International 2010, 107: 656-663. PMID: 20735391, DOI: 10.1111/j.1464-410x.2010.09489.x.
• Identification of Tumor and Invasion Suppressor Gene Modulators in Bladder Cancer by Different Classes of Histone Deacetylase Inhibitors Using Reverse Phase Protein ArraysGould JJ, Kenney PA, Rieger-Christ KM, Neto B, Wszolek MF, LaVoie A, Holway AH, Spurrier B, Austin J, Cammarata BK, Canes D, Libertino JA, Summerhayes IC. Identification of Tumor and Invasion Suppressor Gene Modulators in Bladder Cancer by Different Classes of Histone Deacetylase Inhibitors Using Reverse Phase Protein Arrays. Investigative Urology 2010, 183: 2395-2402. PMID: 20403623, DOI: 10.1016/j.juro.2010.02.004.
• 520 INTEROBSERVER RELIABILITY OF THE RENAL NEPHROMETRY SCORING SYSTEMKenney P, Kozinn S, Wszolek M, Behr S, Lee Y, Libertino J, Moinzadeh A. 520 INTEROBSERVER RELIABILITY OF THE RENAL NEPHROMETRY SCORING SYSTEM. Investigative Urology 2010, 183: e205-e206. DOI: 10.1016/j.juro.2010.02.596.
• 1141 NOVEL ZEB1 EXPRESSION LINKED TO ALTERED MICRORNA EXPRESSION PROFILES IN BLADDER TUMOR PROGRESSIONKenney P, Harty N, Wszolek M, Rieger-Christ K, Neto B, Gould J, Zeheb R, Loda M, Libertino J, Summerhayes I. 1141 NOVEL ZEB1 EXPRESSION LINKED TO ALTERED MICRORNA EXPRESSION PROFILES IN BLADDER TUMOR PROGRESSION. Investigative Urology 2010, 183: e441-e442. DOI: 10.1016/j.juro.2010.02.640.
• Laparoscopic Partial NephrectomyKenney P, Gould J, Tsai S, Canes D. Laparoscopic Partial Nephrectomy. 2010, 187-196. DOI: 10.1007/978-1-84882-178-1_22.
• A MicroRNA expression profile defining the invasive bladder tumor phenotypeWszolek MF, Rieger-Christ KM, Kenney PA, Gould JJ, Neto B, LaVoie AK, Logvinenko T, Libertino JA, Summerhayes IC. A MicroRNA expression profile defining the invasive bladder tumor phenotype. Urologic Oncology Seminars And Original Investigations 2009, 29: 794-801.e1. PMID: 19945312, DOI: 10.1016/j.urolonc.2009.08.024.
• Face, Content, and Construct Validity of dV-Trainer, a Novel Virtual Reality Simulator for Robotic SurgeryKenney PA, Wszolek MF, Gould JJ, Libertino JA, Moinzadeh A. Face, Content, and Construct Validity of dV-Trainer, a Novel Virtual Reality Simulator for Robotic Surgery. Urology 2009, 73: 1288-1292. PMID: 19362352, DOI: 10.1016/j.urology.2008.12.044.
• VALIDATION OF THE DV-TRAINER ®, A NOVEL VIRTUAL REALITY SIMULATOR FOR ROBOTIC SURGERYKenney P, Wszolek M, Gould J, Libertino J, Moinzadeh A. VALIDATION OF THE DV-TRAINER ®, A NOVEL VIRTUAL REALITY SIMULATOR FOR ROBOTIC SURGERY. Investigative Urology 2009, 181: 792. DOI: 10.1016/s0022-5347(09)62206-0.
• IDENTIFICATION OF MODULATORS OF TUMOR AND INVASIVE SUPPRESSOR GENES BY DIFFERENT CLASSES OF HISTONE DEACETYLASE INHIBITORS USING REVERSE PHASE PROTEIN ARRAYSGould J, Kenney P, Wszolek M, Rieger-Christ K, Neto B, Holway A, Spurrier B, Austin J, Libertino J, Summerhayes I. IDENTIFICATION OF MODULATORS OF TUMOR AND INVASIVE SUPPRESSOR GENES BY DIFFERENT CLASSES OF HISTONE DEACETYLASE INHIBITORS USING REVERSE PHASE PROTEIN ARRAYS. Investigative Urology 2009, 181: 346. DOI: 10.1016/s0022-5347(09)60985-x.
• A MICRORNA EXPRESSION PROFILE INVOLVED IN THE INVASIVE BLADDER TUMOR PHENOTYPEWszolek M, Gould J, Kenney P, Rieger-Christ K, Neto B, LaVoie A, Libertino J, Summerhayes I. A MICRORNA EXPRESSION PROFILE INVOLVED IN THE INVASIVE BLADDER TUMOR PHENOTYPE. Investigative Urology 2009, 181: 347. DOI: 10.1016/s0022-5347(09)60987-3.
• Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancerKenney PA, Tuerk IA. Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancer. World Journal Of Urology 2008, 26: 561-569. PMID: 18594824, DOI: 10.1007/s00345-008-0299-3.
• Spirometric correlates of dyspnea improvement among emergency department patients with chronic obstructive pulmonary disease exacerbation.Camargo CA, Tsai CL, Clark S, Kenney PA, Radeos MS. Spirometric correlates of dyspnea improvement among emergency department patients with chronic obstructive pulmonary disease exacerbation. Respiratory Care 2008, 53: 892-6. PMID: 18593490, PMCID: PMC3523353.